331 related articles for article (PubMed ID: 31399022)
1. High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.
Li G; Fan L; Wang Y; Huang L; Wang M; Zhu C; Hao C; Ji W; Liang H; Yan Y; Chen Z
Mol Med; 2019 Aug; 25(1):38. PubMed ID: 31399022
[TBL] [Abstract][Full Text] [Related]
2. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.
Ding Y; Chu C; Li Y; Li G; Lei X; Zhou W; Chen Z
BMC Infect Dis; 2018 Aug; 18(1):439. PubMed ID: 30157804
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children.
Wang M; Wang Y; Yan Y; Zhu C; Huang L; Shao X; Xu J; Zhu H; Sun X; Ji W; Chen Z
Int J Infect Dis; 2014 Dec; 29():18-23. PubMed ID: 25449230
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and refractory mycoplasma pneumoniae pneumonia in children: a systematic review.
Yu M; Zhang Q; Yan H
Minerva Pediatr (Torino); 2024 Apr; 76(2):259-267. PubMed ID: 37155205
[TBL] [Abstract][Full Text] [Related]
5. [Value of autotaxin in predicting refractory
Fu BB; Zhong LL; Ye TT; Han YM; Qiu XC
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):765-770. PubMed ID: 35894191
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.
Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
Microbiol Spectr; 2021 Dec; 9(3):e0158821. PubMed ID: 34937175
[TBL] [Abstract][Full Text] [Related]
7. Distribution and Expression of IL-17 and Related Cytokines in Children with Mycoplasma pneumoniae Pneumonia.
Fan H; Lu B; Yang D; Zhang D; Shi T; Lu G
Jpn J Infect Dis; 2019 Nov; 72(6):387-393. PubMed ID: 31257245
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia.
Fan Y; Ding Y; Li Y; Zhang D; Yu M; Zhou WF; Kong X
Ital J Pediatr; 2022 May; 48(1):64. PubMed ID: 35505407
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of chemokines (CCL 2) in bronchoalveolar lavage fluid for refractory mycoplasma pneumonia in children.
Zhu J; Liu X; Zhan X; Wang M; Zhang Y; Na L; Li S
Ital J Pediatr; 2023 Sep; 49(1):125. PubMed ID: 37740208
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between galectin-3 level in bronchoalveolar lavage fluid and cellular immunity in children with refractory Mycoplasma pneumoniae pneumonia].
Zhao QY; Shi SJ; Sun DQ; Zhang SS; Zhou XH
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):150-154. PubMed ID: 30782277
[TBL] [Abstract][Full Text] [Related]
11. [Value of chitinase-like protein YKL-40 in bronchoalveolar lavage fluid for predicting refractory
Huang LL; Huang DP; Lu LL; Li J; Peng SM
Zhongguo Dang Dai Er Ke Za Zhi; 2021 May; 23(5):471-474. PubMed ID: 34020736
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.
Kannan TR; Coalson JJ; Cagle M; Musatovova O; Hardy RD; Baseman JB
J Infect Dis; 2011 Nov; 204(10):1596-604. PubMed ID: 21957154
[TBL] [Abstract][Full Text] [Related]
13. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.
Techasaensiri C; Tagliabue C; Cagle M; Iranpour P; Katz K; Kannan TR; Coalson JJ; Baseman JB; Hardy RD
Am J Respir Crit Care Med; 2010 Sep; 182(6):797-804. PubMed ID: 20508214
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory
Zhao F; Liu J; Xiao D; Liu L; Gong J; Xu J; Li H; Zhao S; Zhang J
Front Cell Infect Microbiol; 2020; 10():553739. PubMed ID: 33194797
[No Abstract] [Full Text] [Related]
15. [Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels].
Lan Y; Yang D; Chen Z; Tang L; Xu Y; Cheng Y
Zhonghua Er Ke Za Zhi; 2015 Oct; 53(10):779-83. PubMed ID: 26758116
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.
Hardy RD; Coalson JJ; Peters J; Chaparro A; Techasaensiri C; Cantwell AM; Kannan TR; Baseman JB; Dube PH
PLoS One; 2009 Oct; 4(10):e7562. PubMed ID: 19859545
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.
Fan F; Lv J; Yang Q; Jiang F
Clin Respir J; 2023 Jul; 17(7):607-617. PubMed ID: 37142438
[TBL] [Abstract][Full Text] [Related]
18. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.
Kannan TR; Musatovova O; Balasubramanian S; Cagle M; Jordan JL; Krunkosky TM; Davis A; Hardy RD; Baseman JB
Mol Microbiol; 2010 Jun; 76(5):1127-41. PubMed ID: 20199607
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia.
Zhan XW; Deng LP; Wang ZY; Zhang J; Wang MZ; Li SJ
Ital J Pediatr; 2022 Nov; 48(1):190. PubMed ID: 36435821
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal RNA‑depleted RNA sequencing reveals the pathogenesis of refractory
Huang F; Fan H; Yang D; Zhang J; Shi T; Zhang D; Lu G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
